CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A, the CARTO™ 3 EP Navigation System, is an AI-powered 3D cardiac mapping and navigation system primarily used by electrophysiologists during interventional procedures like ablation for heart rhythm disorders. In contrast, Tool B, the LINQ II Insertable Cardiac Monitor, is an AI-powered implantable device designed for long-term, continuous heart rhythm monitoring to diagnose arrhythmias. While both leverage AI in cardiology, they serve distinct purposes: one for real-time procedural guidance and treatment, and the other for extended diagnostic monitoring.

Choose CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 if…

Choose CARTO™ 3 EP Navigation System Software V8.0 if your electrophysiology lab requires an advanced, AI-powered 3D mapping and navigation system for real-time diagnosis and treatment of complex arrhythmias such as AFib and VT. This tool is ideal for guiding catheter ablation procedures, offering precise anatomical mapping and enhanced signal analysis to optimize procedural efficiency and outcomes.

View CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 →

Choose LINQ II Insertable Cardiac Monitor if…

Choose LINQ II Insertable Cardiac Monitor if you need a long-term, continuous heart rhythm monitoring solution for patients experiencing infrequent or unexplained symptoms, or for post-ablation follow-up. This device is best suited for passive, extended monitoring, leveraging AI algorithms for accurate arrhythmia detection and offering remote management capabilities for convenient patient care.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 LINQ II Insertable Cardiac Monitor
Deployment On-premise (system with specialized hardware) Subcutaneous implant with remote monitoring via mobile app or home communicator.
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

LINQ II Insertable Cardiac Monitor

Tool B offers a broader scope of usability by extending its features to patients through a mobile app and home communicator, simplifying data transmission and patient engagement in their long-term monitoring. While Tool A provides efficiency for highly specialized clinicians in a procedural setting, Tool B's patient-centric approach makes it more broadly usable across the care continuum.

Clinical Value

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

Both tools offer significant clinical value in cardiology. However, Tool A's direct role in guiding complex interventional treatment procedures (ablation) for life-threatening arrhythmias, with its real-time 3D mapping and AI-enhanced signal analysis, provides a more immediate and profound impact on procedural success and patient outcomes during critical interventions. Tool B excels in long-term diagnostic monitoring.

Pricing & Value

Tie

Both tools operate with opaque, enterprise-level pricing models that require direct consultation or negotiation, and neither offers a free trial. Without any public pricing information or details on value-based contracting, it is impossible to distinguish between the two on this dimension.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Tool B demonstrates stronger enterprise readiness with its explicit target of 'Solo to large health systems' and a proven track record of over a million patients worldwide. Its hybrid deployment and clear HIPAA compliance further support its scalability and integration into diverse healthcare environments.

Innovation

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

Tool A showcases a higher degree of specialized innovation by integrating multiple AI and machine learning modules for real-time 3D cardiac mapping, navigation, and enhanced signal analysis during complex interventional procedures. This direct application of AI to guide intricate surgical interventions is more cutting-edge within its domain compared to Tool B's AI for diagnostic monitoring.

Support & Docs

LINQ II Insertable Cardiac Monitor

Tool B appears to offer more comprehensive and readily accessible support and documentation, catering to both clinicians and patients with dedicated phone support, patient manuals, and online resources for its mobile app and home communicator. While Tool A provides technical documentation for professionals, Tool B's broader range of support channels and patient-focused materials suggests a more robust overall support ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 LINQ II Insertable Cardiac Monitor
Name CARTOu2122 3 EP Navigation System Software V8.0 (FG-5400-00 LINQ II Insertable Cardiac Monitor
Company Biosense Webster, Inc. Medtronic
Description The CARTOu2122 3 EP Navigation System Software V8.0 by Biosense Webster is an FDA-cleared, AI-powered 3D cardiac mapping and navigation system for electrophysiologists, enhancing diagnosis and treatment of heart rhythm disorders like AFib and VT. The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias.
Tagline Efficiency at Heart. Excellence at Hand. Advanced insertable cardiac monitoring with AI-powered accuracy and remote management.
Key Features Advanced Catheter Location (ACL) technology for accurate catheter visualization, Fast Anatomical Mapping (FAM) for rapid, high-resolution 3D cardiac maps, Connection of Choice for streamlined workflow and automatic catheter recognition, CARTO ELEVATEu2122 Module with machine learning for enhanced signal analysis and substrate characterization, CARTOSOUNDu2122 FAM Module utilizing AI/deep-learning for automated 3D left atrial anatomy creation, Enhanced CONFIDENSEu2122 Module for optimized map creation and data validation, LAT Velocity Vectors for visualizing activation wave velocity over substrate maps, Stability+ algorithm for continuous analysis of ablation catheter movement AccuRhythmu2122 AI algorithms for enhanced accuracy, Remote programming capability, Up to 4.5 years of continuous monitoring, MRI compatibility (1.5 and 3.0T), MyCareLink Heartu2122 mobile app for data transmission, MyCareLink Relayu2122 home communicator option, Innovative PVC detection algorithm, Pediatric indication (ages 2+)

Videos

Demos, reviews, and walkthroughs featuring CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 and LINQ II Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The CARTOu2122 3 EP Navigation System Software V8.0 is an AI-powered 3D cardiac mapping and navigation system designed for electrophysiologists to enhance the diagnosis and treatment of heart rhythm disorders like AFib and VT during interventional procedures. The Medtronic LINQ II Insertable Cardiac Monitor provides long-term, continuous heart rhythm monitoring with remote programming for diagnosing arrhythmias in an ambulatory setting.
The CARTOu2122 3 EP Navigation System utilizes AI for advanced 3D cardiac mapping, enhanced signal analysis through the CARTO ELEVATEu2122 Module, and automated 3D left atrial anatomy creation with the CARTOSOUNDu2122 FAM Module. The LINQ II Insertable Cardiac Monitor employs AccuRhythmu2122 AI algorithms for enhanced accuracy in detecting and classifying arrhythmias, including an innovative PVC detection algorithm, and has been shown to reduce false alerts for AF and pause.
The CARTOu2122 3 EP Navigation System is used during a specific electrophysiology procedure for real-time mapping and navigation. In contrast, the LINQ II Insertable Cardiac Monitor offers long-term, continuous heart rhythm monitoring for up to 4.5 years, with data transmitted remotely by the patient.
The Medtronic LINQ II Insertable Cardiac Monitor has a pediatric indication for patients aged 2 years and older. The CARTOu2122 3 EP Navigation System's product description states it can be used on patients eligible for a conventional electrophysiological procedure with no special contraindications, and studies have shown its use in pediatric supraventricular tachyarrhythmias.
AI Tool Finder
AI-powered search. Results may not be comprehensive.